retatrutide peptide eli lilly The result of the late stage trial is another boost to Lilly's booming obesity business — weight-loss drugs have helped propel the US company to become the first pharmaceuticals group to eli lily retatrutide Lilly's tirzepatide

Your healthcare team can also review whether your current GLP-1 dose remains appropriate or whether adjustment might improve tolerability whilst maintaining therapeutic benefit

Farxiga is considered a first-line option for heart failure prevention in people with type 2 diabetes, and recent research confirms that SGLT2 inhibitors like Farxiga offer stronger protection against heart failure and kidney outcomes

Accessed June 25, 2023, Centers for Disease Control and Prevention

A provider needs to know if symptoms become severe, if dehydration is developing, if abdominal pain raises concern for pancreatitis, or if there are signs suggesting the medication is not being tolerated properly

Takenaka K, Fujii T, Kawamoto A, Suzuki K, Shimizu H, Maeyashiki C, Yamaji O, Motobayashi M, Igarashi A, Hanazawa R, Hibiya S